We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

49 hedge funds and large institutions have $134M invested in Protara Therapeutics in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 9

0% more funds holding

Funds holding: 49 → 49 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

2.35% less ownership

Funds ownership: 78.29% → 75.94% (-2.3%)

37% less capital invested

Capital invested by funds: $212M → $134M (-$78.5M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
0.86%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
19
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$5.46M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.48M
3
MS
Maven Securities
Jersey
+$1.43M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.13M
5
Wells Fargo
Wells Fargo
California
+$1.02M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$18.9M
2
PA
Perceptive Advisors
New York
-$3.47M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.12M
4
TLP
Tri Locum Partners
New York
-$950K
5
EP
Eversept Partners
New York
-$879K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$494K +$265K +14,290 +84%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$404K +$10.1K +543 +2%
TD Asset Management
28
TD Asset Management
Ontario, Canada
$396K – – –
SSA
29
Schonfeld Strategic Advisors
New York
$371K +$435K +23,455 New
AA
30
ALPS Advisors
Colorado
$319K +$3.88K +209 +1%
DMK
31
David M. Knott
$226K – – –
N
32
Nuveen
North Carolina
$219K -$199K -10,707 -43%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$191K -$137K -7,400 -38%
Charles Schwab
34
Charles Schwab
California
$190K – – –
PAM
35
Panagora Asset Management
Massachusetts
$93K +$110K +5,921 New
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$92K – – –
Bank of America
37
Bank of America
North Carolina
$65K +$32.9K +1,772 +76%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$50K – – –
Deutsche Bank
39
Deutsche Bank
Germany
$39K -$4.34K -234 -9%
TRCT
40
Tower Research Capital (TRC)
New York
$27K +$11.2K +606 +54%
JP Morgan Chase
41
JP Morgan Chase
New York
$24K -$2.97K -160 -9%
UBS Group
42
UBS Group
Switzerland
$23K +$14.4K +776 +117%
Morgan Stanley
43
Morgan Stanley
New York
$21K -$76.9K -4,148 -75%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$15K +$6.84K +369 +62%
Legal & General Group
45
Legal & General Group
United Kingdom
$8K – – –
SO
46
STRS Ohio
Ohio
$7K – – –
Citigroup
47
Citigroup
New York
$4K -$8.47K -457 -64%
AIP
48
Ameritas Investment Partners
Nebraska
$3K – – –
CIAS
49
CBIZ Investment Advisory Services
Ohio
$1K – – –
AIG
50
American International Group
New York
$35 +$93 +5 +0.2%
1
2
3

TARA Hedge Fund Activity: Q1 2021 in Review

49 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q1 2021, worth a combined $134M — down 37% from $212M a quarter earlier.

Fund positioning in TARA was balanced in Q1 2021: 5 funds opened new positions, 5 closed out, 19 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $5.46M. The largest seller was Deerfield Management, exiting entirely with an estimated $18.9M sold.

  • 49 institutional investors held Protara Therapeutics (TARA) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $134M of Protara Therapeutics stock for Q1 2021, down 37% quarter-over-quarter.
  • 5 funds opened new Protara Therapeutics positions in Q1 2021 and 5 closed out, a net change of 0 holders.
  • The largest Protara Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $5.46M added.
  • The largest Protara Therapeutics seller in Q1 2021 was Deerfield Management, an estimated $18.9M sold.

Based on aggregated 13F filings for Q1 2021.